BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6766338)

  • 1. Misonidazole also radiosensitizes some normal tissue.
    Arcangeli G; Nervi C; Mauro F
    Br J Radiol; 1980 Jan; 53(625):44-5. PubMed ID: 6766338
    [No Abstract]   [Full Text] [Related]  

  • 2. New side effect of the hypoxic cell sensitizer, misonidazole.
    Partington J; Koziol D; Chapman D; Rabin H; Urtasun RC
    Cancer Treat Rep; 1979 Jan; 63(1):123-5. PubMed ID: 217536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nature and incidence of misonidazole-produced ototoxicity.
    Waltzman SB; Cooper JS
    Arch Otolaryngol; 1981 Jan; 107(1):52-4. PubMed ID: 7469881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurotoxicity of misonidazole: pooling of data from five centres.
    Disch S; Saunders MI; Anderson P; Urtasun RC; Karcher KH; Kogelnik HD; Bleehen N; Phillips TL; Wasserman TH
    Br J Radiol; 1978 Dec; 51(612):1023-4. PubMed ID: 216455
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma concentration of misonidazole and peripheral neuropathy.
    Marten TR
    Am J Clin Oncol; 1982 Apr; 5(2):239-40. PubMed ID: 6283876
    [No Abstract]   [Full Text] [Related]  

  • 6. Modification of the oral radiation death syndrome with combined WR-2721 and misonidazole.
    Grigsby P; Maruyama Y
    Br J Radiol; 1981 Nov; 54(647):969-72. PubMed ID: 6272925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of hearing after misonidazole.
    Abratt RP; Blackburn JD
    Br J Radiol; 1980 Dec; 53(636):1208. PubMed ID: 7437740
    [No Abstract]   [Full Text] [Related]  

  • 8. Split course multiple daily fractionated radiotherapy schedule combined with misonidazole for the management of grade III and IV gliomas. A pilot feasibility study of the Radiotherapy Group of the EORTC.
    Ang KK; van der Schueren E; Notter G; Horiot JC; Chenal C; Fauchon F; Raps J; van Peperzeel H; Goffin JC; Vessière M; van Glabbeke M
    Int J Radiat Oncol Biol Phys; 1982 Oct; 8(10):1657-64. PubMed ID: 6818185
    [No Abstract]   [Full Text] [Related]  

  • 9. The neurotoxicity of misonidazole: potential modifying role of dexamethasone.
    Workman P
    Br J Radiol; 1980 Jul; 53(631):736. PubMed ID: 7426903
    [No Abstract]   [Full Text] [Related]  

  • 10. Oncogenic transformations in vitro produced by misonidazole.
    Miller RC; Hall EJ
    Cancer Clin Trials; 1980; 3(1):85-90. PubMed ID: 7389040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone.
    Wasserman TH; Phillips TL; Van Raalte G; Urtasun R; Partington J; Koziol D; Schwade JG; Gangji D; Strong JM
    Br J Radiol; 1980 Feb; 53(626):172-3. PubMed ID: 6245744
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurotoxicity with desmethylmisonidazole.
    Dische S; Saunders MI; Stratford MR
    Br J Radiol; 1981 Feb; 54(638):156-7. PubMed ID: 6257319
    [No Abstract]   [Full Text] [Related]  

  • 13. Skin rashes associated with the administration of the 2-nitroimidazole, misonidazole.
    Saunders MI; Dische S; Kogelnik HD; Sealy R; Lenox-Smith I
    Cancer Treat Rep; 1980; 64(2-3):263-8. PubMed ID: 6447539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Misonidazole neuropathy.
    Paulson OB; Melgaard B; Hansen HS; Kamieniecka Z; Køhler O; Hansen JM; Pedersen AG; Tang X; Trojaborg W
    Acta Neurol Scand Suppl; 1984; 100():133-6. PubMed ID: 6091392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation in vitro of the chromosomal effects of misonidazole.
    Schwartz LE; Gerd CR; Miller RC
    Int J Radiat Oncol Biol Phys; 1980 Jul; 6(7):915-21. PubMed ID: 7204132
    [No Abstract]   [Full Text] [Related]  

  • 16. Misonidazole & radiotherapy in the palliative treatment of lung cancer.
    Mameghan H; Heller EH
    Australas Radiol; 1983 Nov; 27(3):246-53. PubMed ID: 6202291
    [No Abstract]   [Full Text] [Related]  

  • 17. Combinations of radiation and misonidazole in a murine lung tumor model.
    Siemann DW; Kochanski K
    Radiat Res; 1981 May; 86(2):387-97. PubMed ID: 7232698
    [No Abstract]   [Full Text] [Related]  

  • 18. Misonidazole peripheral neuropathy: its relationship to plasma concentration and other drugs.
    Walker MD; Strike TA
    Cancer Clin Trials; 1980; 3(2):105-9. PubMed ID: 6253094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misonidazole in the clinic at Mount Vernon.
    Dische S
    Cancer Clin Trials; 1980; 3(2):175-8. PubMed ID: 7000388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotoxicity of Adriamycin and misonidazole in the mouse.
    Boegman RJ; Scarth B; Dragovic L; Robertson DM
    Exp Neurol; 1985 Jan; 87(1):1-8. PubMed ID: 2981696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.